It was also reported that the OGG1 mRNA transcripts were reduced in MCI (due to AD pathology) and AD patients, and also patients expressing normal (which includes MCI patients with no AD pathology and patients with subjective cognitive impairment) and abnormal levels of Aβ42 and tau, as compared to healthy controls. The gene discussed is MAPT; the disease is Alzheimer disease.